Changyong Feng
Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Dental Restoration Failure | 3 | 2009 | 11 |
Why?
| Dental High-Speed Equipment | 2 | 2009 | 4 |
Why?
| Dental Implants | 3 | 2005 | 21 |
Why?
| Analgesics, Opioid | 2 | 2009 | 37 |
Why?
| Emergency Service, Hospital | 2 | 2009 | 94 |
Why?
| Dental Porcelain | 3 | 2005 | 9 |
Why?
| Metal Ceramic Alloys | 3 | 2005 | 7 |
Why?
| Dental Abutments | 4 | 2005 | 7 |
Why?
| Urinary Bladder Neoplasms | 4 | 2006 | 44 |
Why?
| Crowns | 3 | 2009 | 15 |
Why?
| Dental Veneers | 2 | 2009 | 5 |
Why?
| Hydromorphone | 2 | 2009 | 5 |
Why?
| Quality of Life | 8 | 2006 | 188 |
Why?
| Morphine | 2 | 2009 | 38 |
Why?
| Hormone Antagonists | 2 | 2006 | 26 |
Why?
| Mifepristone | 2 | 2006 | 30 |
Why?
| Uterine Neoplasms | 2 | 2006 | 52 |
Why?
| Dental Prosthesis Design | 2 | 2009 | 12 |
Why?
| Hematuria | 2 | 2006 | 20 |
Why?
| Post and Core Technique | 1 | 2009 | 5 |
Why?
| Dental Casting Technique | 1 | 2009 | 8 |
Why?
| Tooth Preparation, Prosthodontic | 1 | 2009 | 2 |
Why?
| Dental High-Speed Technique | 1 | 2009 | 2 |
Why?
| Tooth Preparation | 1 | 2009 | 3 |
Why?
| Leiomyoma | 1 | 2010 | 34 |
Why?
| Survival Analysis | 2 | 2002 | 205 |
Why?
| Gingiva | 1 | 2008 | 13 |
Why?
| Dental Impression Technique | 1 | 2008 | 5 |
Why?
| Dental Implantation, Endosseous | 1 | 2008 | 13 |
Why?
| Latex Hypersensitivity | 1 | 2007 | 4 |
Why?
| Health Personnel | 1 | 2007 | 54 |
Why?
| Occupational Diseases | 1 | 2007 | 51 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 251 |
Why?
| Denture, Partial, Fixed | 1 | 2005 | 10 |
Why?
| Dental Prosthesis, Implant-Supported | 1 | 2005 | 14 |
Why?
| Periodontal Diseases | 1 | 2005 | 25 |
Why?
| Statistics, Nonparametric | 3 | 2009 | 141 |
Why?
| Mass Screening | 1 | 2006 | 125 |
Why?
| Middle Aged | 16 | 2005 | 1161 |
Why?
| Asian Continental Ancestry Group | 3 | 2007 | 23 |
Why?
| Humans | 31 | 2002 | 1856 |
Why?
| Dental Stress Analysis | 3 | 2009 | 5 |
Why?
| Adult | 15 | 2002 | 1317 |
Why?
| Materials Testing | 3 | 2008 | 28 |
Why?
| Surface Properties | 3 | 2008 | 63 |
Why?
| Pain Measurement | 3 | 2006 | 98 |
Why?
| Infusions, Intravenous | 2 | 2009 | 87 |
Why?
| Male | 19 | 2002 | 1553 |
Why?
| Logistic Models | 3 | 2008 | 251 |
Why?
| Dental Models | 2 | 2008 | 11 |
Why?
| Female | 18 | 2002 | 1643 |
Why?
| Uterus | 2 | 2006 | 49 |
Why?
| Arthritis, Psoriatic | 2 | 2007 | 9 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2010 | 176 |
Why?
| Attitude to Health | 2 | 2008 | 106 |
Why?
| Outcome Assessment (Health Care) | 2 | 2009 | 163 |
Why?
| Analysis of Variance | 2 | 2009 | 339 |
Why?
| Reproducibility of Results | 6 | 2007 | 391 |
Why?
| Prospective Studies | 3 | 2008 | 545 |
Why?
| Psychometrics | 5 | 2007 | 97 |
Why?
| Pain | 3 | 2006 | 191 |
Why?
| Questionnaires | 4 | 2007 | 360 |
Why?
| Osteoclasts | 2 | 2007 | 48 |
Why?
| Stem Cells | 2 | 2007 | 107 |
Why?
| Prostatic Neoplasms | 2 | 2010 | 120 |
Why?
| Lung Neoplasms | 2 | 2007 | 159 |
Why?
| Aged | 9 | 2005 | 988 |
Why?
| Resin Cements | 2 | 2009 | 4 |
Why?
| Organ Size | 2 | 2006 | 118 |
Why?
| Follow-Up Studies | 3 | 2002 | 553 |
Why?
| Temperature | 2 | 2009 | 137 |
Why?
| Phosphates | 2 | 2009 | 71 |
Why?
| African Americans | 2 | 2009 | 108 |
Why?
| Bioreactors | 1 | 2011 | 8 |
Why?
| Palatine Tonsil | 1 | 2011 | 20 |
Why?
| Esthetics, Dental | 1 | 2011 | 14 |
Why?
| Methamphetamine | 1 | 2010 | 9 |
Why?
| Proportional Hazards Models | 2 | 2002 | 123 |
Why?
| Somatosensory Cortex | 1 | 2010 | 24 |
Why?
| Light Coagulation | 1 | 2010 | 4 |
Why?
| Semen | 1 | 2010 | 15 |
Why?
| Amyloid | 1 | 2010 | 15 |
Why?
| China | 5 | 2007 | 34 |
Why?
| Sample Size | 1 | 2010 | 24 |
Why?
| Stochastic Processes | 1 | 2010 | 22 |
Why?
| Benzothiazoles | 1 | 2010 | 22 |
Why?
| Central Nervous System Stimulants | 1 | 2010 | 32 |
Why?
| Blindness | 1 | 2010 | 22 |
Why?
| Risk-Taking | 2 | 2007 | 36 |
Why?
| Diabetic Retinopathy | 1 | 2010 | 14 |
Why?
| Cementation | 2 | 2005 | 9 |
Why?
| Age of Onset | 1 | 2010 | 64 |
Why?
| Tissue Kallikreins | 1 | 2010 | 7 |
Why?
| Antibody-Producing Cells | 1 | 2010 | 20 |
Why?
| Breast Neoplasms | 2 | 2007 | 185 |
Why?
| Multicenter Studies as Topic | 1 | 2010 | 70 |
Why?
| Dental Marginal Adaptation | 1 | 2009 | 2 |
Why?
| Robotics | 1 | 2011 | 21 |
Why?
| Metallurgy | 1 | 2009 | 9 |
Why?
| Dental Prosthesis Retention | 1 | 2009 | 6 |
Why?
| Dental Casting Investment | 1 | 2009 | 5 |
Why?
| Dental Alloys | 1 | 2009 | 10 |
Why?
| Cerebrovascular Circulation | 1 | 2010 | 62 |
Why?
| Anisotropy | 1 | 2009 | 23 |
Why?
| Tissue Engineering | 1 | 2011 | 25 |
Why?
| Dose-Response Relationship, Drug | 2 | 2010 | 431 |
Why?
| Prostatectomy | 1 | 2011 | 29 |
Why?
| Lymphocytes | 1 | 2011 | 142 |
Why?
| Receptors, IgG | 1 | 2010 | 30 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2010 | 39 |
Why?
| Algorithms | 2 | 2009 | 226 |
Why?
| Tungsten Compounds | 1 | 2009 | 2 |
Why?
| Diamond | 1 | 2009 | 3 |
Why?
| Dental Pulp | 1 | 2009 | 8 |
Why?
| Air | 1 | 2009 | 31 |
Why?
| Prosthodontics | 1 | 2009 | 6 |
Why?
| Single-Blind Method | 1 | 2009 | 86 |
Why?
| Electricity | 1 | 2009 | 14 |
Why?
| Anemia | 1 | 2010 | 60 |
Why?
| Reference Standards | 1 | 2009 | 35 |
Why?
| Body Temperature | 1 | 2009 | 44 |
Why?
| Shear Strength | 1 | 2009 | 13 |
Why?
| Microscopy, Electron, Scanning | 1 | 2009 | 69 |
Why?
| Antibody Formation | 1 | 2010 | 89 |
Why?
| Tensile Strength | 1 | 2009 | 27 |
Why?
| Biological Markers | 2 | 2008 | 262 |
Why?
| Unsafe Sex | 1 | 2008 | 4 |
Why?
| Immunoglobulin G | 2 | 2007 | 191 |
Why?
| Neoplasm Staging | 2 | 2006 | 125 |
Why?
| Writing | 1 | 2008 | 14 |
Why?
| Medetomidine | 1 | 2008 | 4 |
Why?
| Ketamine | 1 | 2008 | 12 |
Why?
| Hot Temperature | 1 | 2009 | 93 |
Why?
| Pilot Projects | 2 | 2006 | 264 |
Why?
| Blood Pressure | 1 | 2010 | 205 |
Why?
| Gold Alloys | 1 | 2008 | 5 |
Why?
| Interviews as Topic | 1 | 2009 | 94 |
Why?
| Computer Simulation | 1 | 2010 | 134 |
Why?
| Dental Impression Materials | 1 | 2008 | 4 |
Why?
| Calcium Sulfate | 1 | 2008 | 7 |
Why?
| Aged, 80 and over | 4 | 2006 | 599 |
Why?
| Prevalence | 2 | 2007 | 281 |
Why?
| Resins, Synthetic | 1 | 2008 | 6 |
Why?
| Polyvinyls | 1 | 2008 | 8 |
Why?
| Microscopy | 1 | 2008 | 31 |
Why?
| Equipment Design | 1 | 2009 | 132 |
Why?
| Siloxanes | 1 | 2008 | 9 |
Why?
| Biometry | 1 | 2007 | 32 |
Why?
| Gloves, Protective | 1 | 2007 | 1 |
Why?
| Ethnic Groups | 1 | 2009 | 95 |
Why?
| Stress, Physiological | 1 | 2008 | 76 |
Why?
| Influenza Vaccines | 1 | 2010 | 70 |
Why?
| Internship and Residency | 1 | 2011 | 175 |
Why?
| Wisconsin | 1 | 2006 | 6 |
Why?
| Patient Satisfaction | 1 | 2009 | 120 |
Why?
| Antirheumatic Agents | 1 | 2007 | 23 |
Why?
| Leiomyomatosis | 1 | 2006 | 10 |
Why?
| Sickness Impact Profile | 1 | 2007 | 26 |
Why?
| Time | 1 | 2006 | 41 |
Why?
| Sexual Behavior | 1 | 2007 | 37 |
Why?
| Demography | 1 | 2006 | 87 |
Why?
| Sex Factors | 1 | 2009 | 284 |
Why?
| Treatment Outcome | 4 | 2005 | 661 |
Why?
| Influenza, Human | 1 | 2010 | 94 |
Why?
| Substance-Related Disorders | 1 | 2008 | 96 |
Why?
| Sodium Bicarbonate | 1 | 2006 | 10 |
Why?
| Denture Precision Attachment | 1 | 2005 | 3 |
Why?
| Tooth Mobility | 1 | 2005 | 7 |
Why?
| Denture Retention | 1 | 2005 | 6 |
Why?
| Composite Resins | 1 | 2005 | 10 |
Why?
| Alveolar Bone Loss | 1 | 2005 | 12 |
Why?
| Denture, Overlay | 1 | 2005 | 12 |
Why?
| Cohort Studies | 1 | 2009 | 332 |
Why?
| Epinephrine | 1 | 2006 | 53 |
Why?
| Occupational Exposure | 1 | 2007 | 53 |
Why?
| Lidocaine | 1 | 2006 | 49 |
Why?
| Stress, Psychological | 1 | 2008 | 117 |
Why?
| Anesthetics, Local | 1 | 2006 | 50 |
Why?
| Comorbidity | 1 | 2006 | 190 |
Why?
| Predictive Value of Tests | 1 | 2006 | 321 |
Why?
| HIV-1 | 1 | 2010 | 93 |
Why?
| Retrospective Studies | 2 | 2005 | 653 |
Why?
| Dental Caries | 1 | 2005 | 38 |
Why?
| Cation Transport Proteins | 1 | 2002 | 17 |
Why?
| Time Factors | 4 | 2008 | 896 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2002 | 17 |
Why?
| New York | 3 | 2008 | 422 |
Why?
| Potassium Channels | 1 | 2002 | 33 |
Why?
| Neoplasms | 1 | 2008 | 239 |
Why?
| Arrhythmias, Cardiac | 1 | 2002 | 65 |
Why?
| Prognosis | 3 | 2002 | 388 |
Why?
| Trans-Activators | 1 | 2002 | 113 |
Why?
| Long QT Syndrome | 1 | 2002 | 35 |
Why?
| Flow Cytometry | 2 | 2010 | 216 |
Why?
| Heart Rate | 2 | 2008 | 138 |
Why?
| Adolescent | 4 | 2002 | 891 |
Why?
| DNA-Binding Proteins | 1 | 2002 | 204 |
Why?
| Cells, Cultured | 2 | 2010 | 447 |
Why?
| Smiling | 1 | 2011 | 4 |
Why?
| Tooth Fractures | 1 | 2011 | 6 |
Why?
| Diastema | 1 | 2011 | 5 |
Why?
| Tooth Loss | 1 | 2011 | 13 |
Why?
| Blood Circulation Time | 1 | 2010 | 5 |
Why?
| Phentolamine | 1 | 2010 | 10 |
Why?
| Cerebral Veins | 1 | 2010 | 10 |
Why?
| Laser-Doppler Flowmetry | 1 | 2010 | 18 |
Why?
| Personal Satisfaction | 1 | 2011 | 19 |
Why?
| Adrenergic alpha-Antagonists | 1 | 2010 | 16 |
Why?
| Competitive Bidding | 1 | 2010 | 4 |
Why?
| Risk Assessment | 2 | 2002 | 324 |
Why?
| Virus Attachment | 1 | 2010 | 7 |
Why?
| Jurkat Cells | 1 | 2010 | 26 |
Why?
| Vasoconstriction | 1 | 2010 | 37 |
Why?
| Aluminum Silicates | 1 | 2010 | 4 |
Why?
| Molecular Structure | 1 | 2010 | 67 |
Why?
| Potassium Compounds | 1 | 2010 | 5 |
Why?
| Hemagglutination Inhibition Tests | 1 | 2010 | 28 |
Why?
| Virion | 1 | 2010 | 24 |
Why?
| Thiazoles | 1 | 2010 | 50 |
Why?
| Antibodies | 1 | 2011 | 159 |
Why?
| Self Concept | 1 | 2011 | 65 |
Why?
| Genetic Markers | 1 | 2010 | 78 |
Why?
| Respiration, Artificial | 1 | 2010 | 81 |
Why?
| Disease-Free Survival | 1 | 2010 | 102 |
Why?
| Alleles | 1 | 2010 | 108 |
Why?
| Stress, Mechanical | 1 | 2010 | 93 |
Why?
| Cell Lineage | 1 | 2010 | 60 |
Why?
| Cell Separation | 1 | 2010 | 110 |
Why?
| Cell Survival | 1 | 2011 | 229 |
Why?
| SEER Program | 1 | 2009 | 22 |
Why?
| Poisson Distribution | 1 | 2008 | 18 |
Why?
| Nursing Methodology Research | 1 | 2008 | 20 |
Why?
| Anesthetics, Dissociative | 1 | 2008 | 3 |
Why?
| Drug Administration Routes | 1 | 2008 | 10 |
Why?
| Condoms | 1 | 2008 | 9 |
Why?
| Animals | 3 | 2008 | 1031 |
Why?
| Restraint, Physical | 1 | 2008 | 20 |
Why?
| Health Status Disparities | 1 | 2009 | 25 |
Why?
| Factor Analysis, Statistical | 1 | 2008 | 45 |
Why?
| Risk Reduction Behavior | 1 | 2008 | 26 |
Why?
| Genotype | 1 | 2010 | 175 |
Why?
| Adolescent Psychology | 1 | 2008 | 20 |
Why?
| Cell Line, Tumor | 1 | 2010 | 208 |
Why?
| Vaccination | 1 | 2010 | 92 |
Why?
| Monocytes | 1 | 2010 | 124 |
Why?
| Bone Marrow Diseases | 1 | 2007 | 31 |
Why?
| Finger Joint | 1 | 2007 | 15 |
Why?
| Cluster Analysis | 1 | 2007 | 66 |
Why?
| Wrist Joint | 1 | 2007 | 19 |
Why?
| Respiration | 1 | 2008 | 78 |
Why?
| Recurrence | 1 | 2010 | 261 |
Why?
| Knee Joint | 1 | 2007 | 30 |
Why?
| Hypnotics and Sedatives | 1 | 2008 | 45 |
Why?
| Protein Binding | 1 | 2010 | 256 |
Why?
| Macaca mulatta | 1 | 2008 | 71 |
Why?
| European Continental Ancestry Group | 1 | 2009 | 117 |
Why?
| Cell Count | 1 | 2007 | 163 |
Why?
| Edema | 1 | 2007 | 67 |
Why?
| Data Interpretation, Statistical | 1 | 2007 | 109 |
Why?
| Kinetics | 1 | 2010 | 349 |
Why?
| Adolescent Behavior | 1 | 2008 | 40 |
Why?
| Motivation | 1 | 2008 | 85 |
Why?
| Practice Guidelines as Topic | 1 | 2009 | 174 |
Why?
| B-Lymphocytes | 1 | 2011 | 134 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 67 |
Why?
| Injections, Intradermal | 1 | 2006 | 15 |
Why?
| Buffers | 1 | 2006 | 29 |
Why?
| Longitudinal Studies | 1 | 2007 | 195 |
Why?
| Young Adult | 1 | 2010 | 380 |
Why?
| Solutions | 1 | 2006 | 54 |
Why?
| Cytokines | 1 | 2010 | 207 |
Why?
| Drug Combinations | 1 | 2006 | 95 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 145 |
Why?
| Mice, Inbred C57BL | 1 | 2010 | 318 |
Why?
| Cross-Sectional Studies | 1 | 2007 | 253 |
Why?
| Age Factors | 1 | 2008 | 480 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 176 |
Why?
| Severity of Illness Index | 1 | 2007 | 358 |
Why?
| Double-Blind Method | 1 | 2006 | 274 |
Why?
| Risk Factors | 1 | 2009 | 555 |
Why?
| Ether-A-Go-Go Potassium Channels | 1 | 2002 | 9 |
Why?
| DNA Mutational Analysis | 1 | 2002 | 110 |
Why?
| Magnetic Resonance Imaging | 1 | 2007 | 294 |
Why?
| Registries | 1 | 2002 | 83 |
Why?
| Odds Ratio | 1 | 2002 | 157 |
Why?
| HIV Infections | 1 | 2007 | 136 |
Why?
| Regression Analysis | 1 | 2002 | 256 |
Why?
| Models, Molecular | 1 | 2002 | 102 |
Why?
| Disease Progression | 1 | 2002 | 244 |
Why?
| Binding Sites | 1 | 2002 | 213 |
Why?
| Mice | 1 | 2010 | 623 |
Why?
| Phenotype | 1 | 2002 | 303 |
Why?
| Electrocardiography | 1 | 2002 | 132 |
Why?
| Mutation | 1 | 2002 | 340 |
Why?
|
|
Feng's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
